| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.938 | 0.001 | 0.942 | Alpha-N-acetylglucosaminidase inhibitor | 0.942 0.001 DBMET02088 0.444 0.007 DBMET02089 | DBMET02088 | |
| 0.926 | 0.003 | 0.926 | Hypoglycemic | 0.799 0.004 DBMET02088 0.201 0.111 DB03501 0.201 0.111 DB01861 | ||
| 0.893 | 0.002 | 0.893 | Alcohol oxidase inhibitor | 0.081 0.024 DBMET02088 | ||
| 0.803 | 0.004 | 0.845 | Immunomodulator | 0.804 0.004 DBMET02088 0.845 0.004 DBMET02089 0.645 0.008 DB03501 0.645 0.008 DB01861 | DBMET02089 | |
| 0.796 | 0.001 | 0.796 | Triose-phosphate isomerase inhibitor | 0.71 0.001 DBMET02088 0.765 0.001 DBMET02089 0.486 0.003 DB03501 0.486 0.003 DB01861 | ||
| 0.77 | 0.002 | 0.825 | Amylase inhibitor | 0.825 0.001 DBMET02088 0.311 0.017 DBMET02089 | DBMET02088 | |
| 0.701 | 0.014 | 0.935 | Cyclophilin D inhibitor | 0.935 0.004 DBMET02088 0.603 0.027 DBMET02089 0.365 0.112 DB03501 0.365 0.112 DB01861 | DBMET02088 | |
| 0.655 | 0.012 | 0.655 | Aldehyde oxidase inhibitor | |||
| 0.629 | 0.001 | 0.963 | Phosphofructokinase-1 inhibitor | 0.638 0.001 DBMET02088 0.693 0.001 DBMET02089 0.963 0 DB03501 0.963 0 DB01861 | DB01861 | |
| 0.591 | 0.001 | 0.965 | UDP-glucose 4-epimerase inhibitor | 0.647 0.001 DBMET02088 0.664 0.001 DBMET02089 0.965 0 DB03501 0.965 0 DB01861 | DB01861 | |
| 0.615 | 0.049 | 0.914 | Antiinflammatory | 0.914 0.005 DBMET02088 0.866 0.008 DBMET02089 0.345 0.176 DB03501 0.345 0.176 DB01861 | DBMET02088 | |
| 0.549 | 0.001 | 0.848 | Alpha-mannosidase inhibitor | 0.848 0.001 DBMET02088 0.168 0.004 DBMET02089 | DBMET02088 | |
| 0.536 | 0.001 | 0.857 | Mannosidase inhibitor | 0.857 0.001 DBMET02088 0.152 0.004 DBMET02089 | DBMET02088 | |
| 0.537 | 0.004 | 0.712 | Aldehyde dehydrogenase inhibitor | 0.569 0.004 DBMET02088 0.581 0.004 DBMET02089 0.712 0.003 DB03501 0.712 0.003 DB01861 | DB01861 | |
| 0.513 | 0.002 | 0.887 | Mannose-6-phosphate isomerase inhibitor | 0.526 0.002 DBMET02088 0.887 0.001 DBMET02089 0.272 0.008 DB03501 0.272 0.008 DB01861 | DBMET02089 | |
| 0.486 | 0.001 | 0.954 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.44 0.002 DBMET02088 0.429 0.002 DBMET02089 0.954 0 DB03501 0.954 0 DB01861 | DB01861 | |
| 0.49 | 0.014 | 0.966 | DNA synthesis inhibitor | 0.722 0.004 DBMET02088 0.608 0.007 DBMET02089 0.966 0.001 DB03501 0.966 0.001 DB01861 | DB01861 | |
| 0.442 | 0 | 0.512 | Glucose-6-phosphate isomerase inhibitor | 0.512 0 DBMET02088 0.388 0.001 DBMET02089 0.123 0.003 DB03501 0.123 0.003 DB01861 | DBMET02088 | |
| 0.48 | 0.039 | 0.774 | Immunosuppressant | 0.671 0.006 DBMET02088 0.774 0.004 DBMET02089 0.533 0.025 DB03501 0.533 0.025 DB01861 | DBMET02089 | |
| 0.442 | 0.004 | 0.442 | Succinate dehydrogenase inhibitor | 0.169 0.081 DBMET02088 | ||
| 0.438 | 0.004 | 0.803 | Hexokinase inhibitor | 0.61 0.002 DBMET02088 0.46 0.003 DBMET02089 0.803 0.001 DB03501 0.803 0.001 DB01861 | DB01861 | |
| 0.437 | 0.004 | 0.831 | NADH dehydrogenase inhibitor | 0.764 0.001 DBMET02088 0.687 0.001 DBMET02089 0.831 0 DB03501 0.831 0 DB01861 | DB01861 | |
| 0.437 | 0.005 | 0.527 | Interleukin 6 antagonist | 0.477 0.005 DBMET02088 0.527 0.004 DBMET02089 0.218 0.032 DB03501 0.218 0.032 DB01861 | DBMET02089 | |
| 0.508 | 0.078 | 0.706 | Alpha-glucosidase inhibitor | 0.706 0.033 DBMET02088 | DBMET02088 | |
| 0.467 | 0.044 | 0.467 | 5 Hydroxytryptamine release inhibitor | 0.45 0.051 DBMET02088 | ||
| 0.422 | 0 | 0.422 | Mannitol 2-dehydrogenase inhibitor | 0.033 0.001 DBMET02089 | ||
| 0.417 | 0.018 | 0.417 | Peroxidase inhibitor | 0.113 0.108 DBMET02088 | ||
| 0.45 | 0.057 | 0.71 | Antibacterial | 0.663 0.012 DBMET02088 0.619 0.017 DBMET02089 0.71 0.008 DB03501 0.71 0.008 DB01861 | DB01861 | |
| 0.412 | 0.025 | 0.412 | Superoxide dismutase inhibitor | |||
| 0.382 | 0.004 | 0.423 | Adenylate kinase inhibitor | 0.311 0.006 DBMET02088 0.381 0.004 DBMET02089 0.423 0.003 DB03501 0.423 0.003 DB01861 | DB01861 | |
| 0.421 | 0.044 | 0.79 | Immunostimulant | 0.631 0.013 DBMET02088 0.657 0.011 DBMET02089 0.79 0.004 DB03501 0.79 0.004 DB01861 | DB01861 | |
| 0.417 | 0.067 | 0.474 | Histamine release inhibitor | 0.474 0.039 DBMET02088 | DBMET02088 | |
| 0.355 | 0.009 | 0.631 | Alkylator | 0.534 0.004 DBMET02088 0.496 0.005 DBMET02089 0.631 0.003 DB03501 0.631 0.003 DB01861 | DB01861 | |
| 0.349 | 0.008 | 0.349 | Chelator | 0.13 0.045 DBMET02088 0.224 0.02 DBMET02089 | ||
| 0.36 | 0.03 | 0.36 | Pyruvate kinase inhibitor | 0.276 0.054 DBMET02089 0.203 0.079 DB03501 0.203 0.079 DB01861 | ||
| 0.374 | 0.045 | 0.591 | Vasodilator, coronary | 0.591 0.008 DBMET02088 0.266 0.119 DBMET02089 0.508 0.014 DB03501 0.508 0.014 DB01861 | DBMET02088 | |
| 0.382 | 0.053 | 0.827 | Cholesterol antagonist | 0.827 0.004 DBMET02088 0.48 0.036 DBMET02089 0.253 0.123 DB03501 0.253 0.123 DB01861 | DBMET02088 | |
| 0.344 | 0.02 | 0.762 | Hepatoprotectant | 0.762 0.003 DBMET02088 0.491 0.007 DBMET02089 0.286 0.034 DB03501 0.286 0.034 DB01861 | DBMET02088 | |
| 0.382 | 0.073 | 0.423 | Antiobesity | 0.423 0.057 DBMET02088 | DBMET02088 | |
| 0.411 | 0.104 | 0.888 | Caspase 9 stimulant | 0.888 0.004 DBMET02088 0.829 0.007 DBMET02089 0.829 0.007 DB03501 0.829 0.007 DB01861 | DBMET02088 | |
| 0.275 | 0.004 | 0.996 | Phosphorylase inhibitor | 0.42 0.003 DBMET02088 0.442 0.003 DBMET02089 0.996 0 DB03501 0.996 0 DB01861 | DB01861 | |
| 0.268 | 0.007 | 0.268 | Catalase inhibitor | 0.065 0.059 DBMET02088 | ||
| 0.264 | 0.004 | 0.264 | Glutamate decarboxylase inhibitor | |||
| 0.257 | 0.003 | 0.257 | Factor V inhibitor | |||
| 0.322 | 0.076 | 0.73 | Antithrombotic | 0.73 0.007 DBMET02088 0.719 0.007 DBMET02089 0.603 0.016 DB03501 0.603 0.016 DB01861 | DBMET02088 | |
| 0.246 | 0.005 | 0.246 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.265 | 0.025 | 0.265 | Growth factor agonist | 0.157 0.127 DBMET02088 | ||
| 0.24 | 0.004 | 0.24 | Neuraminidase (influenza) inhibitor | 0.221 0.004 DBMET02088 0.071 0.033 DBMET02089 | ||
| 0.235 | 0.002 | 0.235 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.018 0.008 DBMET02088 0.014 0.012 DB03501 0.014 0.012 DB01861 | ||
| 0.236 | 0.004 | 0.501 | Biliverdin reductase inhibitor | 0.179 0.007 DBMET02088 0.286 0.003 DBMET02089 0.501 0.001 DB03501 0.501 0.001 DB01861 | DB01861 | |
| 0.234 | 0.006 | 0.587 | Carbamoyl phosphate synthetase inhibitor | 0.263 0.005 DBMET02088 0.31 0.004 DBMET02089 0.587 0.001 DB03501 0.587 0.001 DB01861 | DB01861 | |
| 0.239 | 0.011 | 0.85 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.519 0.002 DBMET02088 0.497 0.003 DBMET02089 0.85 0 DB03501 0.85 0 DB01861 | DB01861 | |
| 0.239 | 0.012 | 0.239 | Microtubule formation inhibitor | 0.211 0.017 DBMET02088 0.158 0.034 DBMET02089 | ||
| 0.263 | 0.042 | 0.438 | Peptidyltransferase inhibitor | 0.438 0.005 DBMET02088 0.297 0.026 DBMET02089 0.376 0.009 DB03501 0.376 0.009 DB01861 | DBMET02088 | |
| 0.229 | 0.009 | 0.578 | Mucolytic | 0.325 0.004 DBMET02088 0.199 0.014 DBMET02089 0.578 0.002 DB03501 0.578 0.002 DB01861 | DB01861 | |
| 0.232 | 0.015 | 0.774 | Expectorant | 0.499 0.004 DBMET02088 0.376 0.005 DBMET02089 0.774 0.002 DB03501 0.774 0.002 DB01861 | DB01861 | |
| 0.216 | 0.003 | 0.216 | Glucosylceramidase inhibitor | 0.204 0.003 DBMET02088 | ||
| 0.214 | 0.004 | 0.214 | Neuraminidase inhibitor | 0.159 0.005 DBMET02088 0.062 0.041 DBMET02089 | ||
| 0.207 | 0.007 | 0.691 | Ornithine carbamoyltransferase inhibitor | 0.103 0.015 DBMET02088 0.131 0.011 DBMET02089 0.691 0.002 DB03501 0.691 0.002 DB01861 | DB01861 | |
| 0.208 | 0.018 | 0.208 | Interleukin 1b antagonist | |||
| 0.207 | 0.02 | 0.207 | Aminopeptidase B inhibitor | |||
| 0.216 | 0.035 | 0.525 | Melanin inhibitor | 0.525 0.006 DBMET02088 0.41 0.011 DBMET02089 | DBMET02088 | |
| 0.183 | 0.005 | 0.183 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.261 | 0.084 | 0.779 | 5 Hydroxytryptamine release stimulant | 0.779 0.004 DBMET02088 | DBMET02088 | |
| 0.197 | 0.021 | 0.197 | GABA C receptor agonist | 0.115 0.053 DBMET02088 | ||
| 0.187 | 0.012 | 0.48 | Sphingomyelinase inhibitor | 0.289 0.004 DBMET02088 0.48 0.002 DBMET02089 | DBMET02089 | |
| 0.242 | 0.071 | 0.403 | Hypolipemic | 0.403 0.025 DBMET02088 0.212 0.086 DBMET02089 | DBMET02088 | |
| 0.225 | 0.054 | 0.358 | Nitric-oxide synthase stimulant | 0.358 0.005 DBMET02088 0.212 0.071 DBMET02089 | DBMET02088 | |
| 0.276 | 0.11 | 0.696 | Vasodilator, peripheral | 0.621 0.014 DBMET02088 0.251 0.126 DBMET02089 0.696 0.006 DB03501 0.696 0.006 DB01861 | DB01861 | |
| 0.199 | 0.034 | 0.219 | Arachidonic acid antagonist | 0.195 0.038 DBMET02088 0.219 0.018 DBMET02089 | DBMET02089 | |
| 0.186 | 0.03 | 0.235 | Cholesterol synthesis inhibitor | 0.147 0.046 DBMET02088 0.235 0.02 DBMET02089 | DBMET02089 | |
| 0.172 | 0.016 | 0.285 | Alcohol dehydrogenase inhibitor | 0.142 0.023 DBMET02088 0.131 0.028 DBMET02089 0.285 0.005 DB03501 0.285 0.005 DB01861 | DB01861 | |
| 0.162 | 0.008 | 0.244 | Acyl-CoA dehydrogenase inhibitor | 0.17 0.007 DBMET02088 0.244 0.003 DBMET02089 0.218 0.004 DB03501 0.218 0.004 DB01861 | DBMET02089 | |
| 0.242 | 0.088 | 0.855 | Antioxidant | 0.855 0.004 DBMET02088 0.574 0.013 DBMET02089 0.23 0.095 DB03501 0.23 0.095 DB01861 | DBMET02088 | |
| 0.266 | 0.112 | 0.691 | Apoptosis antagonist | 0.691 0.005 DBMET02088 0.397 0.039 DBMET02089 0.258 0.12 DB03501 0.258 0.12 DB01861 | DBMET02088 | |
| 0.165 | 0.013 | 0.165 | Hematopoietic | 0.096 0.04 DBMET02089 | ||
| 0.167 | 0.016 | 0.21 | Ca2+-transporting ATPase inhibitor | 0.21 0.003 DBMET02088 0.166 0.016 DBMET02089 | DBMET02088 | |
| 0.165 | 0.014 | 0.569 | Glutamate dehydrogenase inhibitor | 0.185 0.011 DBMET02088 0.241 0.008 DBMET02089 0.569 0.003 DB03501 0.569 0.003 DB01861 | DB01861 | |
| 0.171 | 0.022 | 0.171 | Protease inhibitor | |||
| 0.176 | 0.029 | 0.257 | Adenylate cyclase stimulant | 0.246 0.004 DBMET02088 0.257 0.004 DBMET02089 0.148 0.066 DB03501 0.148 0.066 DB01861 | DBMET02089 | |
| 0.156 | 0.011 | 0.761 | Argininosuccinate synthase inhibitor | 0.175 0.009 DBMET02088 0.217 0.007 DBMET02089 0.761 0.001 DB03501 0.761 0.001 DB01861 | DB01861 | |
| 0.324 | 0.182 | 0.324 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.167 | 0.027 | 0.404 | Antineoplastic antibiotic | 0.404 0.005 DBMET02088 0.182 0.024 DBMET02089 0.077 0.06 DB03501 0.077 0.06 DB01861 | DBMET02088 | |
| 0.226 | 0.095 | 0.226 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.173 | 0.045 | 0.456 | Cell wall synthesis inhibitor | 0.367 0.007 DBMET02088 0.354 0.008 DBMET02089 0.456 0.004 DB03501 0.456 0.004 DB01861 | DB01861 | |
| 0.211 | 0.084 | 0.905 | RNA-directed DNA polymerase inhibitor | 0.579 0.006 DBMET02088 0.533 0.009 DBMET02089 0.905 0.001 DB03501 0.905 0.001 DB01861 | DB01861 | |
| 0.138 | 0.012 | 0.292 | Interferon agonist | 0.292 0.003 DBMET02088 0.187 0.007 DBMET02089 | DBMET02088 | |
| 0.265 | 0.141 | 0.265 | GABA C receptor rho-3 antagonist | |||
| 0.139 | 0.015 | 0.139 | Aminopeptidase I inhibitor | 0.064 0.062 DBMET02089 | ||
| 0.182 | 0.058 | 0.603 | Phospholipase C inhibitor | 0.387 0.011 DBMET02088 0.603 0.004 DBMET02089 0.197 0.046 DB03501 0.197 0.046 DB01861 | DBMET02089 | |
| 0.137 | 0.02 | 0.619 | Selectin antagonist | 0.619 0.002 DBMET02088 0.391 0.003 DBMET02089 0.163 0.016 DB03501 0.163 0.016 DB01861 | DBMET02088 | |
| 0.158 | 0.041 | 0.158 | Cathepsin H inhibitor | |||
| 0.152 | 0.037 | 0.152 | Ferrochelatase inhibitor | |||
| 0.118 | 0.003 | 0.118 | Plasmepsin I inhibitor | |||
| 0.12 | 0.006 | 0.12 | Aconitate hydratase inhibitor | |||
| 0.186 | 0.073 | 0.725 | Nitric oxide antagonist | 0.725 0.005 DBMET02088 0.327 0.035 DBMET02089 0.137 0.108 DB03501 0.137 0.108 DB01861 | DBMET02088 | |
| 0.176 | 0.063 | 0.296 | ATPase inhibitor | 0.296 0.006 DBMET02088 | DBMET02088 | |
| 0.158 | 0.047 | 0.224 | Toll-Like receptor 2 antagonist | 0.211 0.019 DBMET02088 0.224 0.015 DBMET02089 | DBMET02089 | |
| 0.203 | 0.102 | 0.459 | Vasodilator | 0.459 0.015 DBMET02088 0.31 0.045 DBMET02089 0.354 0.032 DB03501 0.354 0.032 DB01861 | DBMET02088 | |
| 0.133 | 0.032 | 0.133 | Creatine kinase inhibitor | 0.092 0.069 DBMET02088 0.1 0.059 DBMET02089 | ||
| 0.11 | 0.011 | 0.2 | Protein 50S ribosomal subunit inhibitor | 0.2 0.005 DBMET02088 0.127 0.008 DBMET02089 0.088 0.016 DB03501 0.088 0.016 DB01861 | DBMET02088 | |
| 0.116 | 0.019 | 0.183 | Na+ K+ transporting ATPase inhibitor | 0.183 0.003 DBMET02088 0.127 0.013 DBMET02089 | DBMET02088 | |
| 0.122 | 0.025 | 0.152 | Histidine decarboxylase inhibitor | 0.076 0.045 DBMET02088 0.152 0.019 DBMET02089 | DBMET02089 | |
| 0.098 | 0.004 | 0.098 | Neuraminidase (Influenza A) inhibitor | 0.052 0.021 DBMET02088 | ||
| 0.099 | 0.006 | 0.14 | Adenosine deaminase inhibitor | 0.14 0.003 DBMET02088 0.072 0.012 DBMET02089 0.111 0.004 DB03501 0.111 0.004 DB01861 | DBMET02088 | |
| 0.133 | 0.041 | 0.133 | GABA C receptor antagonist | 0.121 0.052 DBMET02089 | ||
| 0.115 | 0.023 | 0.115 | Keratolytic | 0.078 0.051 DBMET02089 | ||
| 0.158 | 0.068 | 0.471 | Interferon gamma antagonist | 0.471 0.007 DBMET02088 0.133 0.104 DBMET02089 | DBMET02088 | |
| 0.104 | 0.015 | 0.104 | Maillard reaction inhibitor | |||
| 0.12 | 0.04 | 0.12 | GABA C receptor rho-1 antagonist | |||
| 0.173 | 0.092 | 0.726 | Anesthetic general | 0.651 0.004 DBMET02088 0.726 0.003 DBMET02089 0.134 0.132 DB03501 0.134 0.132 DB01861 | DBMET02089 | |
| 0.112 | 0.032 | 0.121 | Ornithine decarboxylase inhibitor | 0.101 0.043 DBMET02088 0.121 0.025 DBMET02089 | DBMET02089 | |
| 0.2 | 0.121 | 0.716 | Interleukin agonist | 0.716 0.003 DBMET02088 0.584 0.005 DBMET02089 0.387 0.021 DB03501 0.387 0.021 DB01861 | DBMET02088 | |
| 0.116 | 0.039 | 0.116 | MAP kinase kinase 1 inhibitor | |||
| 0.16 | 0.086 | 0.16 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.134 | 0.062 | 0.134 | MAP kinase kinase inhibitor | |||
| 0.084 | 0.013 | 0.084 | Sphingosine kinase inhibitor | 0.06 0.038 DBMET02088 | ||
| 0.113 | 0.043 | 0.113 | Electrolyte absorption antagonist | |||
| 0.149 | 0.079 | 0.219 | Diuretic | 0.219 0.038 DBMET02088 | DBMET02088 | |
| 0.072 | 0.005 | 0.27 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.081 0.004 DBMET02088 0.097 0.003 DBMET02089 0.27 0 DB03501 0.27 0 DB01861 | DB01861 | |
| 0.113 | 0.047 | 0.145 | Anabolic | 0.13 0.031 DBMET02088 0.145 0.021 DBMET02089 0.136 0.026 DB03501 0.136 0.026 DB01861 | DBMET02089 | |
| 0.073 | 0.007 | 0.073 | HIV-1 protease inhibitor | |||
| 0.116 | 0.05 | 0.132 | DOPA decarboxylase inhibitor | 0.132 0.033 DBMET02089 | DBMET02089 | |
| 0.119 | 0.054 | 0.119 | Falcipain 3 inhibitor | |||
| 0.099 | 0.038 | 0.099 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.095 0.04 DBMET02089 0.071 0.06 DB03501 0.071 0.06 DB01861 | ||
| 0.078 | 0.017 | 0.078 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.068 | 0.009 | 0.83 | Fumarate hydratase inhibitor | 0.098 0.005 DBMET02088 0.14 0.004 DBMET02089 0.83 0.001 DB03501 0.83 0.001 DB01861 | DB01861 | |
| 0.07 | 0.011 | 0.146 | Heparanase inhibitor | 0.146 0.003 DBMET02088 0.067 0.014 DBMET02089 0.052 0.039 DB03501 0.052 0.039 DB01861 | DBMET02088 | |
| 0.083 | 0.024 | 0.154 | Ribonucleoside-diphosphate reductase inhibitor | 0.053 0.038 DBMET02088 0.051 0.04 DBMET02089 0.154 0.011 DB03501 0.154 0.011 DB01861 | DB01861 | |
| 0.084 | 0.025 | 0.279 | Ribonucleotide reductase inhibitor | 0.06 0.036 DBMET02088 0.06 0.036 DBMET02089 0.279 0.005 DB03501 0.279 0.005 DB01861 | DB01861 | |
| 0.096 | 0.038 | 0.172 | Porphobilinogen synthase inhibitor | 0.172 0.016 DBMET02089 | DBMET02089 | |
| 0.136 | 0.079 | 0.578 | Protein kinase stimulant | 0.578 0.003 DBMET02088 0.405 0.008 DBMET02089 0.147 0.071 DB03501 0.147 0.071 DB01861 | DBMET02088 | |
| 0.204 | 0.147 | 0.386 | Hypoxia-inducible factor 1 alpha inhibitor | 0.386 0.034 DBMET02088 | DBMET02088 | |
| 0.217 | 0.161 | 0.644 | Interleukin 2 agonist | 0.644 0.003 DBMET02088 0.359 0.042 DBMET02089 0.344 0.048 DB03501 0.344 0.048 DB01861 | DBMET02088 | |
| 0.072 | 0.017 | 0.072 | Epithelial sodium channel blocker | |||
| 0.209 | 0.156 | 0.58 | Caspase 3 stimulant | 0.58 0.012 DBMET02088 | DBMET02088 | |
| 0.078 | 0.024 | 0.078 | Caspase 9 inhibitor | |||
| 0.078 | 0.025 | 0.078 | Cathepsin B inhibitor | |||
| 0.078 | 0.029 | 0.078 | Exportin-1 inhibitor | |||
| 0.052 | 0.005 | 0.052 | Calpain 1 inhibitor | |||
| 0.076 | 0.03 | 0.115 | Glutamate (mGluR6) antagonist | 0.069 0.041 DBMET02088 0.115 0.006 DBMET02089 | DBMET02089 | |
| 0.082 | 0.036 | 0.14 | Glycine receptor agonist | 0.14 0.008 DBMET02088 | DBMET02088 | |
| 0.057 | 0.011 | 0.057 | GABA uptake inhibitor | |||
| 0.16 | 0.115 | 0.16 | MAP kinase kinase 5 inhibitor | |||
| 0.162 | 0.117 | 0.204 | Insulin sensitizer | 0.204 0.069 DBMET02088 | DBMET02088 | |
| 0.057 | 0.013 | 0.137 | Sphingosine 1-phosphate receptor 3 agonist | 0.137 0.004 DBMET02089 | DBMET02089 | |
| 0.051 | 0.008 | 0.802 | Uridine phosphorylase inhibitor | 0.163 0.001 DBMET02088 0.146 0.001 DBMET02089 0.802 0 DB03501 0.802 0 DB01861 | DB01861 | |
| 0.082 | 0.039 | 0.082 | GABA B receptor agonist | |||
| 0.054 | 0.013 | 0.433 | Phosphoglycerate kinase inhibitor | 0.127 0.005 DBMET02088 0.086 0.008 DBMET02089 0.433 0.001 DB03501 0.433 0.001 DB01861 | DB01861 | |
| 0.087 | 0.046 | 0.087 | Estrogen-related receptor beta agonist | |||
| 0.162 | 0.121 | 0.506 | Neurotrophic factor enhancer | 0.506 0.004 DBMET02088 0.196 0.081 DBMET02089 | DBMET02088 | |
| 0.056 | 0.015 | 0.087 | Guanylate cyclase inhibitor | 0.083 0.002 DBMET02088 0.083 0.002 DBMET02089 0.087 0.002 DB03501 0.087 0.002 DB01861 | DB01861 | |
| 0.171 | 0.131 | 0.171 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.046 | 0.007 | 0.046 | Prostaglandin EP2 agonist | |||
| 0.134 | 0.095 | 0.167 | Phospholipase A2 inhibitor | 0.167 0.061 DBMET02089 | DBMET02089 | |
| 0.07 | 0.032 | 0.179 | Purinergic P2X1 antagonist | 0.125 0.01 DBMET02088 0.175 0.005 DBMET02089 0.179 0.004 DB03501 0.179 0.004 DB01861 | DB01861 | |
| 0.123 | 0.084 | 0.123 | Interleukin 1 antagonist | |||
| 0.097 | 0.059 | 0.097 | Prolactin inhibitor | |||
| 0.15 | 0.115 | 0.475 | Non-steroidal antiinflammatory agent | 0.41 0.012 DBMET02088 0.475 0.008 DBMET02089 | DBMET02089 | |
| 0.108 | 0.074 | 0.108 | TRPA1 agonist | 0.096 0.094 DBMET02088 | ||
| 0.088 | 0.056 | 0.088 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.051 | 0.019 | 0.051 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.069 | 0.038 | 0.069 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.115 | 0.083 | 0.117 | Sphingosine 1-phosphate receptor 4 antagonist | 0.117 0.078 DBMET02089 | DBMET02089 | |
| 0.056 | 0.027 | 0.071 | Lysophosphatidic acid 3 receptor antagonist | 0.071 0.014 DBMET02089 | DBMET02089 | |
| 0.052 | 0.023 | 0.148 | Toll-Like receptor 2 agonist | 0.148 0.011 DBMET02088 | DBMET02088 | |
| 0.036 | 0.007 | 0.036 | Lysophosphatidic acid receptor 1 agonist | 0.03 0.011 DBMET02089 | ||
| 0.079 | 0.05 | 0.245 | Carbonic anhydrase XIII inhibitor | 0.245 0.009 DBMET02088 0.159 0.02 DBMET02089 | DBMET02088 | |
| 0.071 | 0.044 | 0.071 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.107 | 0.081 | 0.107 | Caspase 3 inhibitor | |||
| 0.051 | 0.026 | 0.056 | Microtubule stabilization | 0.056 0.02 DBMET02088 | DBMET02088 | |
| 0.119 | 0.096 | 0.203 | Neurotrophic factor | 0.203 0.026 DBMET02088 0.117 0.1 DBMET02089 | DBMET02088 | |
| 0.027 | 0.003 | 0.029 | Methylmalonyl-CoA mutase inhibitor | 0.022 0.006 DBMET02088 0.029 0.003 DBMET02089 0.027 0.003 DB03501 0.027 0.003 DB01861 | DBMET02089 | |
| 0.045 | 0.023 | 0.846 | Thymidine kinase inhibitor | 0.114 0.005 DBMET02088 0.091 0.007 DBMET02089 0.846 0.001 DB03501 0.846 0.001 DB01861 | DB01861 | |
| 0.037 | 0.015 | 0.037 | Prostaglandin agonist | |||
| 0.03 | 0.009 | 0.03 | Prostaglandin F2 alpha agonist | |||
| 0.025 | 0.004 | 0.025 | Lysophosphatidic acid receptor 3 agonist | 0.024 0.004 DBMET02089 | ||
| 0.19 | 0.172 | 0.209 | 5 Hydroxytryptamine uptake stimulant | 0.209 0.135 DBMET02088 | DBMET02088 | |
| 0.155 | 0.138 | 0.677 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.425 0.006 DBMET02088 0.417 0.007 DBMET02089 0.677 0.001 DB03501 0.677 0.001 DB01861 | DB01861 | |
| 0.097 | 0.08 | 0.181 | Cystathionine beta-synthase inhibitor | 0.181 0.029 DBMET02088 | DBMET02088 | |
| 0.048 | 0.031 | 0.097 | Thymidylate synthase inhibitor | 0.044 0.036 DBMET02089 0.097 0.004 DB03501 0.097 0.004 DB01861 | DB01861 | |
| 0.039 | 0.023 | 0.059 | Glutamate (mGluR8) agonist | 0.059 0.007 DBMET02089 | DBMET02089 | |
| 0.045 | 0.03 | 0.045 | Sphingosine 1-phosphate receptor agonist | |||
| 0.042 | 0.027 | 0.042 | Sphingosine kinase 1 inhibitor | 0.041 0.03 DBMET02088 | ||
| 0.029 | 0.013 | 0.116 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.046 0.004 DBMET02088 0.116 0.002 DB03501 0.116 0.002 DB01861 | DB01861 | |
| 0.124 | 0.109 | 0.124 | Thiol protease inhibitor | |||
| 0.024 | 0.009 | 0.024 | Neuraminidase (Influenza B) inhibitor | |||
| 0.019 | 0.006 | 0.019 | Thromboxane A2 agonist | |||
| 0.054 | 0.041 | 0.054 | Beta 1 adrenoreceptor antagonist | |||
| 0.017 | 0.004 | 0.017 | 3C-Like protease (MERS coronavirus) inhibitor | |||
| 0.097 | 0.085 | 0.097 | Anesthetic local | |||
| 0.034 | 0.023 | 0.034 | Calcitonin receptor agonist | |||
| 0.025 | 0.014 | 0.025 | Prostaglandin E2 agonist | |||
| 0.053 | 0.042 | 0.055 | Sphingosine kinase 2 inhibitor | 0.055 0.038 DBMET02088 | DBMET02088 | |
| 0.085 | 0.075 | 0.085 | ABCA1 expression enhancer | |||
| 0.042 | 0.033 | 0.052 | Geranyltranstransferase inhibitor | 0.052 0.02 DBMET02089 | DBMET02089 | |
| 0.019 | 0.01 | 0.071 | Ileal bile acid transport inhibitor | 0.071 0.003 DBMET02088 0.016 0.013 DBMET02089 | DBMET02088 | |
| 0.014 | 0.005 | 0.015 | Purine nucleoside phosphorylase inhibitor | 0.011 0.009 DBMET02088 0.015 0.004 DB03501 0.015 0.004 DB01861 | DB01861 | |
| 0.035 | 0.026 | 0.157 | Antibiotic Aminoglycoside-like | 0.157 0.001 DBMET02088 0.096 0.003 DBMET02089 0.066 0.007 DB03501 0.066 0.007 DB01861 | DBMET02088 | |
| 0.071 | 0.063 | 0.071 | Vanilloid 4 agonist | |||
| 0.038 | 0.03 | 0.038 | Membrane dipeptidase inhibitor | |||
| 0.076 | 0.069 | 0.098 | Glutathione S-transferase inhibitor | 0.098 0.039 DBMET02089 | DBMET02089 | |
| 0.188 | 0.182 | 0.696 | Transcription factor NF kappa B inhibitor | 0.696 0.021 DBMET02088 0.459 0.051 DBMET02089 | DBMET02088 | |
| 0.069 | 0.063 | 0.149 | GABA aminotransferase inhibitor | 0.149 0.008 DBMET02088 | DBMET02088 | |
| 0.033 | 0.028 | 0.033 | Renin inhibitor | |||
| 0.02 | 0.015 | 0.024 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.024 0.008 DBMET02088 | DBMET02088 | |
| 0.022 | 0.017 | 0.033 | Isoleucine-tRNA ligase inhibitor | 0.033 0.004 DBMET02088 | DBMET02088 | |
| 0.084 | 0.079 | 0.275 | Glutamate release inhibitor | 0.275 0.004 DBMET02088 | DBMET02088 | |
| 0.025 | 0.021 | 0.214 | Sodium/glucose cotransporter 2 inhibitor | 0.214 0.001 DBMET02088 0.035 0.01 DBMET02089 | DBMET02088 | |
| 0.016 | 0.012 | 0.024 | Adenosine A2 receptor agonist | 0.024 0.006 DBMET02088 | DBMET02088 | |
| 0.097 | 0.094 | 0.303 | Photosensitizer | 0.303 0.004 DBMET02088 | DBMET02088 | |
| 0.025 | 0.021 | 0.025 | Lysine carboxypeptidase inhibitor | |||
| 0.016 | 0.013 | 0.016 | Carbonic anhydrase X inhibitor | |||
| 0.016 | 0.013 | 0.016 | Carbonic anhydrase VIII inhibitor | |||
| 0.134 | 0.131 | 0.136 | Interleukin antagonist | 0.136 0.13 DBMET02088 | DBMET02088 | |
| 0.04 | 0.037 | 0.07 | AICAR transformylase inhibitor | 0.049 0.024 DBMET02088 0.054 0.019 DBMET02089 0.07 0.01 DB03501 0.07 0.01 DB01861 | DB01861 | |
| 0.053 | 0.05 | 0.053 | Pregnane X receptor antagonist | |||
| 0.016 | 0.013 | 0.016 | Vitamin D receptor agonist | |||
| 0.087 | 0.085 | 0.296 | Mediator release inhibitor | 0.296 0.007 DBMET02088 | DBMET02088 | |
| 0.096 | 0.093 | 0.096 | Proteasome inhibitor | |||
| 0.119 | 0.116 | 0.47 | Hemostatic | 0.47 0.005 DBMET02088 0.259 0.021 DBMET02089 | DBMET02088 | |
| 0.045 | 0.043 | 0.045 | Dopamine beta hydroxylase inhibitor | |||
| 0.018 | 0.016 | 0.045 | Antibiotic Anthracycline-like | 0.045 0.002 DBMET02088 | DBMET02088 | |
| 0.047 | 0.046 | 0.047 | Cathepsin D inhibitor | |||
| 0.059 | 0.057 | 0.22 | Interferon inducer | 0.22 0.003 DBMET02088 | DBMET02088 | |
| 0.045 | 0.044 | 0.129 | Aldose reductase inhibitor | 0.129 0.013 DBMET02088 | DBMET02088 | |
| 0.02 | 0.019 | 0.02 | Vitamin D receptor antagonist | |||
| 0.01 | 0.009 | 0.01 | Thromboxane agonist | |||
| 0.016 | 0.015 | 0.078 | Telomerase stimulant | 0.078 0.001 DBMET02088 0.022 0.005 DBMET02089 | DBMET02088 | |
| 0.04 | 0.04 | 0.811 | Antimetabolite | 0.241 0.007 DBMET02088 0.193 0.01 DBMET02089 0.811 0.001 DB03501 0.811 0.001 DB01861 | DB01861 | |
| 0.012 | 0.014 | 0.026 | Adenosine A2a receptor agonist | 0.026 0.006 DBMET02088 | DBMET02088 | |
| 0.111 | 0.112 | 0.198 | Vanilloid 1 agonist | 0.198 0.013 DBMET02088 0.158 0.031 DBMET02089 | DBMET02088 | |
| 0.025 | 0.028 | 0.038 | Purinergic P2Y15 antagonist | 0.038 0.008 DBMET02088 | DBMET02088 | |
| 0.023 | 0.026 | 0.29 | Sodium/glucose cotransporter inhibitor | 0.29 0.001 DBMET02088 0.029 0.012 DBMET02089 0.025 0.019 DB03501 0.025 0.019 DB01861 | DBMET02088 | |
| 0.03 | 0.034 | 0.032 | HMG CoA reductase inhibitor | 0.032 0.028 DBMET02088 | DBMET02088 | |
| 0.029 | 0.033 | 0.03 | Glutamate (mGluR3) agonist | 0.03 0.029 DBMET02088 | DBMET02088 | |
| 0.013 | 0.017 | 0.087 | Purinergic P2Y1 agonist | 0.024 0.005 DBMET02088 0.034 0.003 DBMET02089 0.087 0.001 DB03501 0.087 0.001 DB01861 | DB01861 | |
| 0.085 | 0.09 | 0.236 | Phosphodiesterase 6D inhibitor | 0.236 0.004 DBMET02088 | DBMET02088 | |
| 0.178 | 0.182 | 0.261 | Gastrin inhibitor | 0.261 0.066 DBMET02088 | DBMET02088 | |
| 0.007 | 0.015 | 0.884 | Purinergic P2Y2 agonist | 0.026 0.001 DBMET02088 0.031 0.001 DBMET02089 0.884 0 DB03501 0.884 0 DB01861 | DB01861 | |
| 0.119 | 0.128 | 0.138 | Sphingosine 1-phosphate receptor 5 antagonist | 0.138 0.084 DBMET02089 | DBMET02089 | |
| 0.008 | 0.016 | 0.025 | Antibiotic Macrolide-like | 0.025 0.005 DBMET02088 | DBMET02088 | |
| 0.001 | 0.011 | 0.851 | Purinergic P2Y6 agonist | 0.006 0.001 DBMET02088 0.007 0.001 DBMET02089 0.851 0 DB03501 0.851 0 DB01861 | DB01861 | |
| 0.098 | 0.109 | 0.549 | Bone formation stimulant | 0.131 0.076 DBMET02088 0.549 0.004 DBMET02089 | DBMET02089 | |
| 0.022 | 0.035 | 0.079 | Caspase 2 inhibitor | 0.079 0.006 DBMET02088 0.044 0.014 DBMET02089 | DBMET02088 | |
| 0.007 | 0.021 | 0.017 | Glutamate (mGluR6) agonist | 0.017 0.005 DBMET02089 | DBMET02089 | |
| 0.079 | 0.094 | 0.091 | Interleukin 1 beta converting enzyme inhibitor | 0.091 0.07 DBMET02088 | DBMET02088 | |
| 0.023 | 0.039 | 0.085 | Arginase inhibitor | 0.085 0.005 DBMET02088 | DBMET02088 | |
| 0.198 | 0.217 | 0.432 | Calcium channel activator | 0.246 0.152 DBMET02088 0.432 0.015 DBMET02089 | DBMET02089 | |
| 0.021 | 0.04 | 0.53 | Thymidine phosphorylase inhibitor | 0.057 0.004 DBMET02088 0.071 0.004 DBMET02089 0.53 0.001 DB03501 0.53 0.001 DB01861 | DB01861 | |
| 0.073 | 0.092 | 0.092 | Interleukin 5 antagonist | 0.092 0.051 DBMET02088 | DBMET02088 | |
| 0.059 | 0.081 | 0.076 | Phospholipase D inhibitor | 0.076 0.041 DBMET02088 | DBMET02088 | |
| 0.019 | 0.042 | 0.085 | Vanilloid 2 agonist | 0.085 0.001 DBMET02088 0.045 0.003 DBMET02089 | DBMET02088 | |
| 0.04 | 0.063 | 0.093 | Squalene epoxidase inhibitor | 0.093 0.006 DBMET02088 | DBMET02088 | |
| 0.021 | 0.049 | 0.033 | Lysophosphatidic acid 2 receptor antagonist | 0.033 0.018 DBMET02089 | DBMET02089 | |
| 0.14 | 0.171 | 0.414 | Cyclic AMP phosphodiesterase inhibitor | 0.414 0.015 DBMET02088 0.192 0.1 DBMET02089 0.306 0.04 DB03501 0.306 0.04 DB01861 | DBMET02088 | |
| 0.089 | 0.121 | 0.468 | Cyclooxygenase 3 inhibitor | 0.468 0.003 DBMET02088 0.335 0.005 DBMET02089 | DBMET02088 | |
| 0.038 | 0.078 | 0.16 | Cytokine production stimulant | 0.16 0.002 DBMET02088 0.114 0.004 DBMET02089 | DBMET02088 | |
| 0.071 | 0.112 | 0.125 | Lanosterol 14 alpha demethylase inhibitor | 0.125 0.025 DBMET02088 | DBMET02088 | |
| 0.021 | 0.063 | 0.029 | Caspase 6 inhibitor | 0.029 0.024 DBMET02088 | DBMET02088 | |
| 0.068 | 0.115 | 0.095 | D-Ala-D-Ala ligase inhibitor | 0.095 0.035 DBMET02089 | DBMET02089 | |
| 0.029 | 0.077 | 0.037 | Vanilloid 3 antagonist | 0.037 0.031 DBMET02089 | DBMET02089 | |
| 0.022 | 0.071 | 0.089 | Ceramide glucosyltransferase inhibitor | 0.089 0.003 DBMET02088 0.059 0.004 DBMET02089 0.073 0.003 DB03501 0.073 0.003 DB01861 | DBMET02088 | |
| 0 | 0.051 | 0.348 | Purinergic P2Y4 agonist | 0.005 0.003 DBMET02088 0.055 0.001 DBMET02089 0.348 0 DB03501 0.348 0 DB01861 | DB01861 | |
| 0.209 | 0.261 | 0.817 | Apoptosis agonist | 0.817 0.015 DBMET02088 0.806 0.016 DBMET02089 0.416 0.106 DB03501 0.416 0.106 DB01861 | DBMET02088 | |
| 0.046 | 0.101 | 0.088 | Lipocortins synthesis agonist | 0.088 0.009 DBMET02088 0.085 0.01 DBMET02089 | DBMET02088 | |
| 0.074 | 0.13 | 0.256 | Beta glucuronidase inhibitor | 0.256 0.008 DBMET02088 | DBMET02088 | |
| 0.091 | 0.148 | 0.234 | Antibacterial (Helicobacter pylori) | 0.234 0.014 DBMET02088 | DBMET02088 | |
| 0.055 | 0.117 | 0.365 | Monophenol monooxygenase inhibitor | 0.365 0.013 DBMET02088 | DBMET02088 | |
| 0.009 | 0.074 | 0.025 | Corticosteroid-like | 0.025 0.01 DBMET02088 0.022 0.014 DBMET02089 | DBMET02088 | |
| 0.072 | 0.137 | 0.139 | Protein kinase C gamma inhibitor | 0.139 0.039 DBMET02088 | DBMET02088 | |
| 0.067 | 0.135 | 0.706 | Adenylate cyclase inhibitor | 0.41 0.007 DBMET02088 0.386 0.008 DBMET02089 0.706 0.002 DB03501 0.706 0.002 DB01861 | DB01861 | |
| 0.007 | 0.076 | 0.017 | Adenosine A2b receptor agonist | 0.017 0.007 DBMET02088 0.015 0.009 DB03501 0.015 0.009 DB01861 | DBMET02088 | |
| 0.02 | 0.091 | 0.179 | RNA-directed RNA polymerase inhibitor | 0.179 0.004 DB03501 0.179 0.004 DB01861 | DB01861 | |
| 0.121 | 0.197 | 0.457 | Spasmolytic | 0.457 0.03 DBMET02088 0.161 0.153 DBMET02089 | DBMET02088 | |
| 0.101 | 0.179 | 0.309 | DNA methyltransferase I inhibitor | 0.309 0.023 DBMET02088 | DBMET02088 | |
| 0.095 | 0.174 | 0.129 | Sphingosine 1-phosphate receptor 2 antagonist | 0.129 0.076 DBMET02089 | DBMET02089 | |
| 0.043 | 0.121 | 0.183 | Topoisomerase II alpha inhibitor | 0.183 0.018 DBMET02088 | DBMET02088 | |
| 0.05 | 0.131 | 0.224 | Glycine receptor antagonist | 0.22 0.003 DBMET02088 0.224 0.003 DBMET02089 | DBMET02089 | |
| 0.039 | 0.12 | 0.099 | Protein kinase C beta inhibitor | 0.099 0.014 DBMET02088 | DBMET02088 | |
| 0.118 | 0.201 | 0.312 | Heat shock protein 70 antagonist | 0.173 0.015 DBMET02088 0.185 0.01 DBMET02089 0.312 0.003 DB03501 0.312 0.003 DB01861 | DB01861 | |
| 0.059 | 0.142 | 0.141 | ATPase (Vacuolar H+) inhibitor | 0.141 0.01 DBMET02088 | DBMET02088 | |
| 0.006 | 0.089 | 0.169 | Purinergic P2T antagonist | 0.045 0.01 DBMET02089 0.169 0.004 DB03501 0.169 0.004 DB01861 | DB01861 | |
| 0.003 | 0.086 | 0.612 | Purinergic P2Y agonist | 0.034 0.004 DBMET02088 0.229 0.001 DBMET02089 0.612 0.001 DB03501 0.612 0.001 DB01861 | DB01861 | |
| 0.064 | 0.149 | 0.343 | Xanthine oxidase inhibitor | 0.343 0.005 DBMET02088 0.121 0.047 DBMET02089 | DBMET02088 | |
| 0.003 | 0.09 | 0.609 | Purinergic receptor agonist | 0.039 0.004 DBMET02088 0.252 0.001 DBMET02089 0.609 0.001 DB03501 0.609 0.001 DB01861 | DB01861 | |
| 0.003 | 0.09 | 0.609 | Purinergic P2 agonist | 0.039 0.004 DBMET02088 0.252 0.001 DBMET02089 0.609 0.001 DB03501 0.609 0.001 DB01861 | DB01861 | |
| 0.063 | 0.151 | 0.633 | DNA polymerase I inhibitor | 0.393 0.006 DBMET02088 0.506 0.004 DBMET02089 0.633 0.002 DB03501 0.633 0.002 DB01861 | DB01861 | |
| 0.061 | 0.15 | 0.221 | Carbonic anhydrase III inhibitor | 0.221 0.013 DBMET02088 | DBMET02088 | |
| 0.084 | 0.18 | 0.209 | Sphingosine 1-phosphate receptor 2 agonist | 0.209 0.01 DBMET02089 | DBMET02089 | |
| 0.06 | 0.158 | 0.083 | Thioredoxin reductase inhibitor | 0.083 0.055 DBMET02088 | DBMET02088 | |
| 0.039 | 0.141 | 0.475 | Histone deacetylase SIRT1 stimulant | 0.475 0.004 DBMET02088 0.167 0.007 DBMET02089 | DBMET02088 | |
| 0.039 | 0.141 | 0.475 | Histone deacetylase stimulant | 0.475 0.004 DBMET02088 0.167 0.007 DBMET02089 | DBMET02088 | |
| 0.006 | 0.11 | 0.092 | Adenosine kinase inhibitor | 0.038 0.008 DBMET02088 0.092 0.004 DB03501 0.092 0.004 DB01861 | DB01861 | |
| 0.046 | 0.151 | 0.181 | Carbonic anhydrase VI inhibitor | 0.181 0.015 DBMET02088 | DBMET02088 | |
| 0.1 | 0.207 | 0.255 | CF transmembrane conductance regulator agonist | 0.255 0.005 DBMET02088 | DBMET02088 | |
| 0.007 | 0.116 | 0.059 | Adenosine A1 receptor agonist | 0.059 0.005 DBMET02088 0.048 0.006 DB03501 0.048 0.006 DB01861 | DBMET02088 | |
| 0.023 | 0.135 | 0.051 | Prolyl endopeptidase inhibitor | 0.051 0.034 DBMET02088 | DBMET02088 | |
| 0.027 | 0.146 | 0.104 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.099 0.017 DBMET02088 0.086 0.022 DBMET02089 0.104 0.016 DB03501 0.104 0.016 DB01861 | DB01861 | |
| 0.027 | 0.146 | 0.062 | Androgen agonist | 0.062 0.038 DBMET02088 0.058 0.044 DBMET02089 | DBMET02088 | |
| 0.028 | 0.152 | 0.057 | Topoisomerase II beta inhibitor | 0.057 0.025 DBMET02088 | DBMET02088 | |
| 0.091 | 0.216 | 0.551 | DNA methylase inhibitor | 0.358 0.015 DBMET02088 0.135 0.132 DBMET02089 0.551 0.005 DB03501 0.551 0.005 DB01861 | DB01861 | |
| 0.115 | 0.239 | 0.642 | DNA damaging | 0.642 0.007 DBMET02088 0.358 0.039 DBMET02089 0.488 0.015 DB03501 0.488 0.015 DB01861 | DBMET02088 | |
| 0.028 | 0.155 | 0.082 | HIV-1 integrase (3'-Processing) inhibitor | 0.069 0.039 DBMET02088 0.082 0.033 DBMET02089 | DBMET02089 | |
| 0.022 | 0.149 | 0.08 | HIV-1 integrase (Strand Transfer) inhibitor | 0.072 0.035 DBMET02088 0.08 0.031 DBMET02089 | DBMET02089 | |
| 0.127 | 0.255 | 0.418 | Transcription factor STAT3 inhibitor | 0.191 0.147 DBMET02088 0.418 0.015 DBMET02089 | DBMET02089 | |
| 0.043 | 0.171 | 0.116 | Phosphodiesterase VI inhibitor | 0.116 0.013 DBMET02088 | DBMET02088 | |
| 0.012 | 0.147 | 0.544 | Purinergic P2Y antagonist | 0.179 0.004 DBMET02089 0.544 0.001 DB03501 0.544 0.001 DB01861 | DB01861 | |
| 0.016 | 0.154 | 0.058 | Prostaglandin EP2 antagonist | 0.058 0.043 DBMET02088 | DBMET02088 | |
| 0.01 | 0.158 | 0.116 | Protein 30S ribosomal subunit inhibitor | 0.116 0.002 DBMET02088 0.057 0.007 DBMET02089 0.025 0.016 DB03501 0.025 0.016 DB01861 | DBMET02088 | |
| 0.016 | 0.166 | 0.134 | Carbonic anhydrase XIV inhibitor | 0.134 0.005 DBMET02088 | DBMET02088 | |
| 0.062 | 0.22 | 0.487 | Psychostimulant | 0.153 0.113 DBMET02088 0.487 0.012 DBMET02089 0.479 0.013 DB03501 0.479 0.013 DB01861 | DBMET02089 | |
| 0.065 | 0.224 | 0.233 | Interleukin 4 antagonist | 0.233 0.015 DBMET02088 | DBMET02088 | |
| 0.064 | 0.224 | 0.868 | Angiogenesis stimulant | 0.868 0.003 DBMET02088 0.524 0.01 DBMET02089 0.341 0.035 DB03501 0.341 0.035 DB01861 | DBMET02088 | |
| 0.048 | 0.213 | 0.097 | Bile acid receptor antagonist | 0.097 0.056 DBMET02088 | DBMET02088 | |
| 0.022 | 0.188 | 0.098 | Nitric oxide donor | 0.098 0.01 DBMET02088 | DBMET02088 | |
| 0.004 | 0.171 | 0.048 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.048 0.005 DB03501 0.048 0.005 DB01861 | DB01861 | |
| 0.079 | 0.246 | 0.496 | DNA repair enzyme inhibitor | 0.349 0.004 DBMET02088 0.217 0.007 DBMET02089 0.496 0.003 DB03501 0.496 0.003 DB01861 | DB01861 | |
| 0.006 | 0.174 | 0.145 | Purinergic P2X agonist | 0.033 0.016 DBMET02088 0.113 0.003 DBMET02089 0.145 0.002 DB03501 0.145 0.002 DB01861 | DB01861 | |
| 0.086 | 0.258 | 0.753 | Free radical scavenger | 0.753 0.004 DBMET02088 0.342 0.041 DBMET02089 | DBMET02088 | |
| 0.057 | 0.234 | 0.102 | Glutamate (mGluR7) agonist | 0.102 0.056 DBMET02089 | DBMET02089 | |
| 0.054 | 0.234 | 0.558 | Toll-Like receptor 4 antagonist | 0.294 0.003 DBMET02088 0.558 0.001 DBMET02089 0.212 0.005 DB03501 0.212 0.005 DB01861 | DBMET02089 | |
| 0.062 | 0.244 | 0.17 | Anticoagulant | 0.17 0.066 DBMET02088 | DBMET02088 | |
| 0.076 | 0.263 | 0.373 | Insulin secretagoues | 0.373 0.007 DBMET02088 0.199 0.036 DB03501 0.199 0.036 DB01861 | DBMET02088 | |
| 0.019 | 0.207 | 0.213 | Purinergic P2X2 antagonist | 0.179 0.007 DBMET02089 0.213 0.004 DB03501 0.213 0.004 DB01861 | DB01861 | |
| 0.029 | 0.225 | 0.136 | Potassium channel (Ca-activated) activator | 0.136 0.033 DBMET02089 | DBMET02089 | |
| 0.042 | 0.238 | 0.152 | Phosphodiesterase I inhibitor | 0.152 0.017 DB03501 0.152 0.017 DB01861 | DB01861 | |
| 0.023 | 0.225 | 0.072 | Sphingosine 1-phosphate receptor 5 agonist | 0.072 0.015 DBMET02089 | DBMET02089 | |
| 0.018 | 0.227 | 0.038 | Adenosine uptake inhibitor | 0.038 0.016 DBMET02088 | DBMET02088 | |
| 0.046 | 0.265 | 0.732 | Cytidine deaminase inhibitor | 0.182 0.056 DBMET02088 0.732 0.003 DB03501 0.732 0.003 DB01861 | DB01861 | |
| 0.009 | 0.234 | 0.46 | Inosine monophosphate dehydrogenase inhibitor | 0.04 0.021 DBMET02088 0.124 0.004 DBMET02089 0.46 0.002 DB03501 0.46 0.002 DB01861 | DB01861 | |
| 0.007 | 0.241 | 0.04 | 1,3-Beta-glucan synthase inhibitor | 0.04 0.004 DBMET02088 0.035 0.006 DBMET02089 | DBMET02088 | |
| 0.063 | 0.312 | 0.154 | P-glycoprotein inhibitor | 0.154 0.112 DBMET02088 | DBMET02088 | |
| 0.03 | 0.28 | 0.129 | Adenosine A3 receptor antagonist | 0.129 0.016 DBMET02088 | DBMET02088 | |
| 0.035 | 0.296 | 0.391 | AMP-activated protein kinase stimulant | 0.391 0.004 DBMET02088 0.12 0.049 DBMET02089 0.127 0.043 DB03501 0.127 0.043 DB01861 | DBMET02088 | |
| 0.018 | 0.281 | 0.059 | Purinergic P2X4 antagonist | 0.059 0.016 DB03501 0.059 0.016 DB01861 | DB01861 | |
| 0.01 | 0.28 | 0.081 | Adenosine A1 receptor antagonist | 0.081 0.028 DBMET02088 | DBMET02088 | |
| 0.043 | 0.316 | 0.651 | Transcription factor NF kappa B stimulant | 0.39 0.003 DBMET02088 0.651 0.002 DBMET02089 0.426 0.002 DB03501 0.426 0.002 DB01861 | DBMET02089 | |
| 0.086 | 0.364 | 0.422 | Transcription factor STAT inhibitor | 0.197 0.143 DBMET02088 0.422 0.015 DBMET02089 | DBMET02089 | |
| 0.004 | 0.284 | 0.055 | Squalene synthetase inhibitor | 0.055 0.013 DBMET02089 | DBMET02089 | |
| 0.034 | 0.317 | 0.172 | Alkaline phosphatase inhibitor | 0.172 0.047 DBMET02089 | DBMET02089 | |
| 0.004 | 0.295 | 0.264 | HCV NS5B polymerase inhibitor | 0.264 0.003 DB03501 0.264 0.003 DB01861 | DB01861 | |
| 0.028 | 0.324 | 0.553 | Adenine nucleotide translocase inhibitor | 0.169 0.003 DBMET02088 0.553 0.001 DBMET02089 0.154 0.003 DB03501 0.154 0.003 DB01861 | DBMET02089 | |
| 0.005 | 0.305 | 0.17 | Purinergic P2Y12 antagonist | 0.028 0.013 DBMET02089 0.17 0.004 DB03501 0.17 0.004 DB01861 | DB01861 | |
| 0.037 | 0.337 | 0.225 | Beta amyloid protein antagonist | 0.225 0.011 DBMET02088 0.198 0.017 DBMET02089 | DBMET02088 | |
| 0.004 | 0.307 | 0.063 | Carbonic anhydrase II inhibitor | 0.063 0.033 DBMET02088 | DBMET02088 | |
| 0.005 | 0.31 | 0.082 | Carbonic anhydrase inhibitor | 0.082 0.034 DBMET02088 | DBMET02088 | |
| 0.004 | 0.315 | 0.122 | Carbonic anhydrase XII inhibitor | 0.122 0.016 DBMET02088 | DBMET02088 | |
| 0.004 | 0.319 | 0.059 | Carbonic anhydrase I inhibitor | 0.059 0.036 DBMET02088 | DBMET02088 | |
| 0.04 | 0.358 | 0.117 | Acetylcholine M1 receptor antagonist | 0.117 0.113 DBMET02088 | DBMET02088 | |
| 0.013 | 0.334 | 0.343 | Toll-Like receptor 4 agonist | 0.076 0.002 DBMET02088 0.343 0.001 DBMET02089 0.058 0.003 DB03501 0.058 0.003 DB01861 | DBMET02089 | |
| 0.004 | 0.326 | 0.099 | Carbonic anhydrase IX inhibitor | 0.099 0.02 DBMET02088 | DBMET02088 | |
| 0.049 | 0.392 | 0.155 | Transcription factor STAT6 inhibitor | 0.104 0.095 DBMET02088 0.155 0.02 DBMET02089 | DBMET02089 | |
| 0.027 | 0.38 | 0.197 | Uric acid excretion stimulant | 0.197 0.013 DBMET02088 | DBMET02088 | |
| 0.005 | 0.374 | 0.057 | Adenosine A2a receptor antagonist | 0.057 0.048 DBMET02088 | DBMET02088 | |
| 0.022 | 0.419 | 0.423 | Aminoacyl-tRNA synthetase inhibitor | 0.136 0.023 DBMET02088 0.183 0.012 DBMET02089 0.423 0.004 DB03501 0.423 0.004 DB01861 | DB01861 | |
| 0.03 | 0.428 | 0.112 | Nav1.5 sodium channel blocker | 0.112 0.066 DBMET02088 | DBMET02088 | |
| 0.017 | 0.418 | 0.484 | Topoisomerase I inhibitor | 0.484 0.004 DBMET02088 0.167 0.035 DBMET02089 0.188 0.029 DB03501 0.188 0.029 DB01861 | DBMET02088 | |
| 0.036 | 0.441 | 0.393 | Platelet antagonist | 0.363 0.035 DBMET02088 0.365 0.034 DBMET02089 0.393 0.028 DB03501 0.393 0.028 DB01861 | DB01861 | |
| 0.024 | 0.439 | 0.437 | Thrombolytic | 0.437 0.008 DBMET02088 0.18 0.062 DBMET02089 | DBMET02088 | |
| 0.034 | 0.475 | 0.336 | Antiamyloidogenic | 0.336 0.042 DBMET02088 0.152 0.145 DBMET02089 | DBMET02088 | |
| 0.019 | 0.465 | 0.06 | Factor III inhibitor | 0.06 0.017 DBMET02088 | DBMET02088 | |
| 0.01 | 0.458 | 0.106 | CDC25A inhibitor | 0.101 0.027 DBMET02088 0.106 0.024 DBMET02089 | DBMET02089 | |
| 0.023 | 0.478 | 0.251 | Toll-Like receptor antagonist | 0.116 0.092 DBMET02088 0.251 0.015 DBMET02089 | DBMET02089 | |
| 0.035 | 0.533 | 0.39 | DNA directed DNA polymerase inhibitor | 0.39 0.119 DB03501 0.39 0.119 DB01861 | DB01861 | |
| 0.004 | 0.512 | 0.093 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.033 0.008 DBMET02088 0.082 0.003 DBMET02089 0.093 0.003 DB03501 0.093 0.003 DB01861 | DB01861 | |
| 0.032 | 0.544 | 0.483 | Platelet adhesion inhibitor | 0.483 0.006 DBMET02088 0.209 0.066 DBMET02089 0.32 0.028 DB03501 0.32 0.028 DB01861 | DBMET02088 | |
| 0.016 | 0.54 | 0.078 | Factor IXa inhibitor | 0.078 0.016 DBMET02088 | DBMET02088 | |
| 0.004 | 0.545 | 0.021 | Adenosine A3 receptor agonist | 0.021 0.008 DBMET02088 0.018 0.011 DB03501 0.018 0.011 DB01861 | DBMET02088 | |
| 0.097 | 0.638 | 0.24 | Calcium channel L-type activator | 0.24 0.217 DBMET02088 | DBMET02088 | |
| 0.038 | 0.602 | 0.145 | Folate antagonist | 0.145 0.024 DBMET02089 | DBMET02089 | |
| 0.005 | 0.585 | 0.094 | Protein-tyrosine phosphatase 1B inhibitor | 0.094 0.084 DBMET02089 | DBMET02089 | |
| 0.006 | 0.594 | 0.063 | Protein kinase C alpha inhibitor | 0.063 0.054 DBMET02088 | DBMET02088 | |
| 0.009 | 0.612 | 0.361 | Topoisomerase II inhibitor | 0.361 0.012 DBMET02088 0.117 0.07 DBMET02089 | DBMET02088 | |
| 0.007 | 0.61 | 0.111 | Protein kinase C eta inhibitor | 0.111 0.014 DBMET02088 | DBMET02088 | |
| 0.016 | 0.638 | 0.203 | Potassium channel large-conductance Ca-activated activator | 0.203 0.006 DBMET02089 | DBMET02089 | |
| 0.004 | 0.685 | 0.023 | Motilin receptor agonist | 0.023 0.016 DBMET02088 | DBMET02088 | |
| 0.01 | 0.724 | 0.095 | Glucose-6-phosphate translocase inhibitor | 0.095 0.007 DBMET02088 | DBMET02088 | |
| 0.007 | 0.814 | 0.184 | DNA intercalator | 0.184 0.031 DBMET02088 | DBMET02088 | |
| 0.007 | 0.828 | 0.193 | Purinergic P2Y2 antagonist | 0.104 0.004 DBMET02089 0.193 0.002 DB03501 0.193 0.002 DB01861 | DB01861 | |
| 0.008 | 0.844 | 0.812 | Tumour necrosis factor alpha release inhibitor | 0.627 0.006 DBMET02088 0.812 0.004 DBMET02089 0.237 0.081 DB03501 0.237 0.081 DB01861 | DBMET02089 | |
| 0.005 | 0.844 | 0.514 | Lipid peroxidase inhibitor | 0.514 0.005 DBMET02088 0.275 0.023 DBMET02089 | DBMET02088 | |
| 0.003 | 0.845 | 0.022 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.022 0.005 DBMET02088 | DBMET02088 | |
| 0.024 | 0.872 | 0.756 | NOS3 expression enhancer | 0.756 0.003 DBMET02088 0.36 0.01 DBMET02089 0.126 0.104 DB03501 0.126 0.104 DB01861 | DBMET02088 | |
| 0.004 | 0.859 | 0.078 | Growth factor receptor-bound protein 2 antagonist | 0.078 0.003 DBMET02089 | DBMET02089 | |
| 0.005 | 0.865 | 0.097 | Cell adhesion molecule inhibitor | 0.097 0.036 DBMET02088 | DBMET02088 | |
| 0.007 | 0.87 | 0.189 | Cardiotonic | 0.189 0.13 DBMET02088 | DBMET02088 | |
| 0.015 | 0.887 | 0.079 | T cell inhibitor | 0.079 0.069 DBMET02088 | DBMET02088 | |
| 0.004 | 0.903 | 0.037 | Protein kinase C beta I inhibitor | 0.037 0.014 DBMET02088 | DBMET02088 | |
| 0.005 | 0.906 | 0.454 | Cell adhesion inhibitor | 0.454 0.005 DBMET02088 | DBMET02088 | |
| 0.015 | 0.918 | 0.145 | Interleukin 12 antagonist | 0.145 0.014 DBMET02088 0.103 0.049 DBMET02089 | DBMET02088 | |
| 0.008 | 0.922 | 0.074 | Antiviral (Hepatitis D) | 0.074 0.011 DB03501 0.074 0.011 DB01861 | DB01861 | |
| 0.02 | 0.934 | 0.192 | Catenin beta inhibitor | 0.192 0.039 DBMET02089 | DBMET02089 | |
| 0.04 | 0.961 | 0.133 | CC chemokine 6 receptor antagonist | 0.133 0.058 DBMET02088 | DBMET02088 | |
| 0.005 | 0.931 | 0.223 | Antimitotic | 0.223 0.072 DBMET02089 | DBMET02089 | |
| 0.005 | 0.935 | 0.094 | Breast cancer-resistant protein inhibitor | 0.094 0.061 DBMET02089 | DBMET02089 | |
| 0.003 | 0.947 | 0.253 | Purinergic P2 antagonist | 0.165 0.009 DBMET02089 0.253 0.005 DB03501 0.253 0.005 DB01861 | DB01861 | |
| 0.004 | 0.979 | 0.133 | Cyclooxygenase 1 inhibitor | 0.133 0.068 DBMET02088 | DBMET02088 | |
| 0.004 | 0.984 | 0.196 | Amyloid beta aggregation inhibitor | 0.196 0.08 DBMET02088 | DBMET02088 | |
| 0.004 | 0.99 | 0.261 | Angiogenesis inhibitor | 0.261 0.115 DBMET02088 | DBMET02088 | |
| 0.005 | 0.994 | 0.289 | Thioredoxin inhibitor | 0.289 0.004 DBMET02088 0.122 0.029 DBMET02089 | DBMET02088 | |
| 0.003 | 0.993 | 0.387 | HIV-1 reverse transcriptase inhibitor | 0.072 0.048 DBMET02089 0.387 0.004 DB03501 0.387 0.004 DB01861 | DB01861 | |
| 0.001 | 0.993 | 0.247 | Purinergic P2Y1 antagonist | 0.247 0.002 DBMET02089 0.079 0.003 DB03501 0.079 0.003 DB01861 | DBMET02089 | |
| 0.003 | 0.996 | 0.46 | DNA directed RNA polymerase inhibitor | 0.104 0.052 DBMET02089 0.46 0.004 DB03501 0.46 0.004 DB01861 | DB01861 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |